November 20, 2024
Phyllis Newhouse
President
CID Holdco, Inc.
7500 Old Georgetown Road, Suite 901
Bethesda, Maryland 20814
Edmund Nabrotzky
Chief Executive Officer
SEE ID, Inc.
7500 Old Georgetown Road, Suite 901
Bethesda, Maryland 20814
Re: CID Holdco, Inc.
Amendment No. 2 to the Registration Statement on Form S-4
Filed November 7, 2024
File No. 333-282600
Dear Phyllis Newhouse and Edmund Nabrotzky:
We have reviewed your amended registration statement and have the
following
comments.
Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.
After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments. Unless
we note
otherwise, any references to prior comments are to comments in our October 30,
2024 letter.
Registration Statement on Form S-4
Risk Factors
"Our dependence on a limited number of joint design manufacturers and suppliers
of
manufacturing services and critical components ...", page 52
1. We note your risk factor disclosure that your devices are made using an
outsourced
manufacturing business model that utilizes joint design manufacturers.
We also note
November 20, 2024
Page 2
your disclosure citing your dependence on a limited number of joint
design
manufacturers to allocate sufficient manufacturing capacity to meet your
needs to
produce devices or components. In that regard, please expand your
disclosure to
provide the material terms of each of your agreements with any third
parties you
significantly rely on, including each party s material rights and
obligations,
termination provisions and any payment provisions. Also, please file
each of the
agreements as exhibits in accordance with Item 601 of Regulation S-K.
The Business Combination Proposal, page 97
2. We note your disclosure on page 111 related to the waiver of the
underwriting fee of
Citigroup as your underwriter. Please supplementally provide us with any
correspondence from Citigroup regarding the resignation, including the
letter you
received from Citigroup dated September 19, 2024.
Amendment No. 2 to the Registration Statement on Form S-4
Unaudited Pro Forma Condensed Combined Financial Information
Unaudited Pro Forma Condensed Combined Statements of Operations, page 145
3. Please revise the titles of the pro forma columns under Scenarios 1 - 4
to identify the
information as pro forma income statement information, not pro forma
balance sheet
information.
4. Please provide a pro forma statement of comprehensive income for the
year ended
year ended December 31, 2023, pursuant to Rule 11-02(c) of Regulation
S-X.
Management's Discussion and Analysis of Financial Condition and Results of
Operations of
SUAC, page 156
5. We note your expanded disclosure on page 163 in response to prior
comment 11.
Please describe commercialization activities and clarify if the cost of
such activities is
included in capitalization.
Management's Discussion and Analysis of Financial Condition and Results of
Operations of
See ID, page 176
6. Please revise the column headers of the tables on pages 177 and 178 to
refer to the
correct periods or correct as of date.
7. On page 176 you disclose the platform is due for release in the fourth
quarter of 2024
however the software capitalization table on page 163 indicates the
timing of release
of all software currently in development is the first quarter of 2025.
Please reconcile
these disclosures or advise.
Index to Financial Statements, page F-1
8. Please update your financial statements and related financial
information throughout
in accordance with Rule 8-08 of Regulation S-X.
November 20, 2024
Page 3
See ID, Inc. Financial Statements
Software Development Costs, page F-59
9. We note your response to prior comment 15. Please clarify (1) if the
software released
on July 18, 2024 as indicated in the table on page 163 of the Amendment
was release
1.0 of Gen 1 or something else and (2) what you mean by "previous ones
are already
closed."
Please contact Anastasia Kaluzienski at 202-551-3685 or Robert
Littlepage at 202-
551-3361 if you have questions regarding comments on the financial statements
and related
matters. Please contact Mariam Mansaray at 202-551-6356 or Jan Woo at
202-551-3453 with
any other questions.
Sincerely,
Division of
Corporation Finance
Office of Technology
cc: Gerry Williams
Krisanne Cunningham